Format

Send to

Choose Destination
J Med Chem. 2017 Mar 23;60(6):2245-2256. doi: 10.1021/acs.jmedchem.6b01262. Epub 2017 Mar 13.

A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction.

Author information

1
School of Food Science and Environmental Health, College of Sciences and Health, Dublin Institute of Technology , Cathal Brugha Street, Dublin 1, Ireland.
2
UCD School of Medicine, University College Dublin , Dublin, Ireland.
3
School of Biomolecular and Biomed Science, Conway Institute , Belfield, Dublin 4, Ireland.

Abstract

K+ channels containing Kv1.1 α subunits, which become prevalent at internodes in demyelinated axons, may underlie their dysfunctional conduction akin to muscle weakness in multiple sclerosis. Small inhibitors were sought with selectivity for the culpable hyper-polarizing K+ currents. Modeling of interactions with the extracellular pore in a Kv1.1-deduced structure identified diaryldi(2-pyrrolyl)methane as a suitable scaffold with optimized alkyl ammonium side chains. The resultant synthesized candidate [2,2'-((5,5'(di-p-topyldiaryldi(2-pyrrolyl)methane)bis(2,2'carbonyl)bis(azanediyl)) diethaneamine·2HCl] (8) selectively blocked Kv1.1 channels (IC50 ≈ 15 μM) recombinantly expressed in mammalian cells, induced a positive shift in the voltage dependency of K+ current activation, and slowed its kinetics. It preferentially inhibited channels containing two or more Kv1.1 subunits regardless of their positioning in concatenated tetramers. In slices of corpus callosum from mice subjected to a demyelination protocol, this novel inhibitor improved neuronal conduction, highlighting its potential for alleviating symptoms in multiple sclerosis.

PMID:
28225274
DOI:
10.1021/acs.jmedchem.6b01262
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center